Healthcare -
Biotechnology - NASDAQ - US
$ 33.5
1.73 %
$ 9.57 B
Market Cap
21.61
P/E
EXEL - LONG-TERM INVESTMENTS
Long-term Investments EXEL - Exelixis, Inc.
729 M
LAST VALUE
40.13%
2 YEAR CAGR
35.90%
5 YEAR CAGR
17.58%
10 YEAR CAGR